Roth Capital Upgrades Trinity Biotech (TRIB) to Buy
Tweet
Share
E-mailGet Alerts TRIB Hot Sheet
Price: $9.60 -1.23%
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 4
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 6 | New: 4
Join SI Premium – FREE
Roth Capital upgraded Trinity Biotech (NASDAQ: TRIB) from Neutral to Buy with a price target of $30.00.
For an analyst ratings summary and ratings history on Trinity Biotecjh click here. For more ratings news on Trinity Biotecjh click here.
Shares of Trinity Biotecjh closed at $24.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
- Deutsche Bank Upgrades Dunelm Group PLC (DNLM:LN) to Buy
- Citi Upgrades Telstra Corp. (TLS:AU) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
